Takeda Nears Shire Deal as Japanese Companies Chase Growth Overseas

Takeda is near a deal worth more than $60 billion to buy European drugmaker Shire, having raised its bid four times in a sign of how ardently Japan’s legacy companies are pursuing growth abroad as sales at home slow.

from WSJ.com: US Business https://ift.tt/2I1YSrq
via IFTTT